Contact
Please use this form to send email to PR contact of this press release:
V-Bio Ventures’ Portfolio Company Precirix raises €80m in Series B to advance pipeline of precision radiopharmaceuticals
TO:
Rita Prota
Turnstone Communications
+33 6 15 95 00 62